Related Experiment Video
Updated: Mar 3, 2026
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Substance P Regulation in Epilepsy
Guangfan Chi1, Zhehao Huang2, Xianglan Li2
1The Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun 130021, Jilin, China.
Substance P (SP) plays a role in epilepsy by activating the NK-1 receptor. Blocking this receptor with antagonists may offer a new epilepsy treatment, requiring further investigation.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Epilepsy is a neurological disorder involving abnormal neuronal discharges.
- Neuropeptides, like substance P (SP), are implicated in epilepsy pathogenesis.
- SP's role in epilepsy involves its physiologic and pathologic functions.
Purpose of the Study:
- To review the effects of substance P (SP) in epilepsy.
- To explore the mechanisms underlying SP's role in epilepsy.
- To assess the therapeutic potential of targeting the SP/NK-1 receptor system.
Main Methods:
- Literature review and content collection on SP and epilepsy.
- Analysis of existing research on SP/NK-1 receptor signaling in epilepsy models.
Main Results:
- The SP/NK-1 receptor system contributes to seizures and status epilepticus.
- Excitatory effects of SP/NK-1 signaling in epilepsy are mediated by multiple mechanisms.
- NK-1 receptor antagonists show potential in blocking SP's effects.
Conclusions:
- SP binding to NK-1 receptors is critical in epilepsy.
- The NK-1 receptor is a promising therapeutic target for epilepsy.
- Further research is needed to confirm the anti-epileptic activity of NK-1 receptor antagonists.
More Related Videos
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:32Postsynaptic Potential (PSP)
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...